Unknown PHASE4 INTERVENTIONAL NCT00438217
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children (CPP-EDG 01)
Sponsor: University of Pisa
Conditions
Central Precocious Puberty
Interventions
Leuprolide (GnRH agonists) Triptorelin (GnRH agonists)
Updated 4 times since 2017 Last updated: Feb 21, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Central Precocious Puberty, this trial is ongoing. The trial is conducted by University of Pisa and has accumulated 4 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University of Pisa
Data source: University of Pisa
For direct contact, visit the study record on ClinicalTrials.gov .